ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

ClinicalTrials.gov ID: NCT03301506

Public ClinicalTrials.gov record NCT03301506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Study identification

NCT ID
NCT03301506
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
340 participants

Conditions and interventions

Interventions

  • Seladelpar 10 mg Capsule Drug
  • Seladelpar 5 mg Capsule Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 11, 2017
Primary completion
Oct 31, 2028
Completion
Nov 30, 2028
Last update posted
May 3, 2026

2017 – 2028

United States locations

U.S. sites
40
U.S. states
21
U.S. cities
35
Facility City State ZIP Site status
Arkansas Diagnostic Center Little Rock Arkansas 72205
Stanford University School of Medicine Palo Alto California 94305
California Liver Research Institute Pasadena California 91105
University of California Davis Medical Center Sacramento California 95817
California Pacific Medical Center San Francisco California 94115
University of Colorado - Denver - PPDS Aurora Colorado 80045
Yale University School of Medicine New Haven Connecticut 06510
Covenant Research Fort Myers Fort Myers Florida 33606
Florida Digestive Health Specialist Lakewood Rch Florida 34211
University of Miami Miller School of Medicine Miami Florida 33136
Covenant Research, LLC Sarasota Florida 33912
Digestive Healthcare of Georgia PC Atlanta Georgia 30309
University of Chicago Hospitals Chicago Illinois 60637
East Jefferson General Hospital New Orleans Louisiana 70112
Mercy Medical Center (Baltimore) Baltimore Maryland 21202
Massachusetts General Hospital Boston Massachusetts 02114
Beth Israel Deaconess Medical Center - 330 Brookline Ave Boston Massachusetts 02215
Henry Ford Health System Novi Michigan 48377
MNGI Digestive Health PA-Plymouth Minneapolis Minnesota 55413
Southern Therapy and Advanced Research LLC Jackson Mississippi 39157
Saint Louis University St Louis Missouri 63104
NYU Langone Medical Center New York New York 10021
Weill Cornell Medical College New York New York 10021
Icahn School of Medicine at Mount Sinai New York New York 10029
University of Rochester Medical Center - PPDS Rochester New York 14642
Duke University Medical Center Durham North Carolina 27710
Northeast Clinical Research Center, LLC Bethlehem Pennsylvania 18017
Penn State Health Milton S. Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Galen Medical Group Chattanooga Tennessee 37404
Gastro One-8110 Walnut Run Rd Cordova Tennessee 38018
Vanderbilt University Medical Center Nashville Tennessee 37212
University of Texas Southwestern Medical Center Dallas Texas 39090
Liver Institute at Methodist Dallas Dallas Texas 75203
Baylor College of Medicine Houston Texas 77030
The Texas Liver Institute - 607 Camden St San Antonio Texas 78215 1619
Pinnacle Clinical Research, PLLC San Antonio Texas 78229
Maryview Hospital Inc., d/b/a Bon Secours Liver Institute of Hampton Roads Newport News Virginia 23602
Bon Secours Richmond Community Hospital, Inc. d/b/a Bon Secours Liver Institute of Richmond Richmond Virginia 23226
Liver Institute Northwest, PLLC Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03301506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03301506 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →